Craig Gracey Sells 2,083 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $21.00, for a total value of $43,743.00. Following the sale, the chief accounting officer directly owned 858 shares in the company, valued at $18,018. This trade represents a 70.83% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Craig Gracey also recently made the following trade(s):

• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The stock was sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Trading Up 1.3%

Shares of Omada Health stock traded up $0.28 on Tuesday, reaching $21.95. The stock had a trading volume of 853,685 shares, compared to its average volume of 1,070,637. The business’s 50 day moving average is $16.83 and its two-hundred day moving average is $14.93. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The company has a market cap of $1.30 billion and a P/E ratio of -81.30.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, equities analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently commented on OMDA. Citizens Jmp boosted their price target on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research report on Friday, May 8th. Morgan Stanley reiterated an “overweight” rating and issued a $30.00 price objective on shares of Omada Health in a research report on Monday, June 22nd. Wells Fargo & Company lifted their price objective on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Needham & Company LLC restated a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Finally, Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday. Ten investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $22.91.

Hedge Funds Weigh In On Omada Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Omada Health during the fourth quarter valued at about $1,222,000. Divisadero Street Capital Management LP purchased a new position in shares of Omada Health in the 3rd quarter worth about $30,510,000. a16z Perennial Management L.P. bought a new position in shares of Omada Health during the 4th quarter valued at about $2,480,000. Madryn Asset Management LP purchased a new position in shares of Omada Health during the 4th quarter valued at about $9,212,000. Finally, Independent Advisor Alliance purchased a new position in shares of Omada Health during the 4th quarter valued at about $717,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.